NCAPD2 anticorps (AA 1101-1300) (Biotin)
Aperçu rapide pour NCAPD2 anticorps (AA 1101-1300) (Biotin) (ABIN886283)
Antigène
Voir toutes NCAPD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 1101-1300
-
Réactivité croisée
- Souris
-
Homologie
- Human,Rat,Dog,Cow,Sheep,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human CAPD2
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C for 12 months.
-
Date de péremption
- 12 months
-
-
- NCAPD2 (Non-SMC Condensin I Complex, Subunit D2 (NCAPD2))
-
Autre désignation
- CAPD2
-
Sujet
-
Synonyms: CAPD2, Chromosome condensation-related SMC-associated protein 1, Chromosome-associated protein D2, CND1, Condensin, hCAP-D2, hCAPD2, CND1_HUMAN.
Background: CAPD2 is a regulatory subunit of the condensin complex, a complex required for conversion of interphase chromatin into mitotic-like condensed chromosomes. The condensin complex probably introduces positive supercoils into relaxed DNA in the presence of type I topoisomerases and converts nicked DNA into positive knotted forms in the presence of type II topoisomerases. It may target the condensin complex to DNA via its C-terminal domain (referenced from Swissprot).
-
ID gène
- 9918
Antigène
-